Tyzavan Injection, Solution
Product Images NDC 0143-9469

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Tyzavan (NDC 0143-9469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tyzavan Vancomycin Injection 1)

Chemical structure of Vancomycin hydrochloride, depicting its molecular arrangement with chlorine, hydroxyl, amino groups, and multiple ring systems.*

FDA Label Image

1g 200ml Bag Label (Tyzavan Vancomycin Injection 10)

Label for TYZAVAN 1 g/200 mL vancomycin injection solution in a single-dose flexible bag for intravenous infusion. The label notes it is sterile, nonpyrogenic, ready to use, and not for supplementary medication. Manufactured by Hikma Pharmaceuticals USA Inc., the label includes storage instructions, dosage cautions, and barcode with NDC 0143-9472-01.*

FDA Label Image

1g 200ml Ow (Tyzavan Vancomycin Injection 11)

TYZAVAN 1 g/200 mL (vancomycin injection, USP) intravenous injection solution single-dose flexible bag. The label highlights it as a new formulation, sterile, nonpyrogenic, and ready to use. Manufactured for Hikma Pharmaceuticals USA Inc., made in Switzerland. Includes usage instructions and storage conditions on the label.*

FDA Label Image

1g 200ml Ctn06 (Tyzavan Vancomycin Injection 12)

TYZAVAN 1 g/200 mL (5 mg/mL) intravenous injection solution carton label. The label indicates the product contains vancomycin injection, USP, and is intended for intravenous infusion only. It features a red and white color scheme with hexagonal design elements and includes storage instructions to keep at 15°C to 25°C (59°F to 77°F). Labeler is Hikma Pharmaceuticals USA Inc. The label also states "Ready To Use" and "New Formulation."*

FDA Label Image

1g 200ml Ctn12 (Tyzavan Vancomycin Injection 13)

Packaging label for TYZAVAN 1 g/200 mL (5 mg/mL) injection solution, vancomycin injection, USP. The product is for intravenous infusion, labeled as ready to use and sterile. The label notes that the package contains twelve single-dose flexible bags. Manufacturer is Hikma Pharmaceuticals USA Inc. Storage instructions specify 15°C to 25°C (59°F to 77°F).*

FDA Label Image

1.25g Bag Label (Tyzavan Vancomycin Injection 14)

TYZAVAN 1.25 g/250 mL (Vancomycin injection, USP) intravenous injection solution label. Single-dose flexible bag labeled as sterile and nonpyrogenic. Manufactured for Hikma Pharmaceuticals USA Inc. Instructions include infusion over at least 60 minutes, storage conditions, and formulation details. Label highlights 'New Formulation' and 'Ready To Use.' Barcode and QR code present.*

FDA Label Image

1.25 250ml Ow (Tyzavan Vancomycin Injection 15)

TYZAVAN 1.25 g/250 mL (vancomycin injection, USP) intravenous injection solution in a single-dose flexible bag. Label states sterile, nonpyrogenic, ready to use, and for intravenous infusion only. Manufactured by Hikma Pharmaceuticals USA Inc. The label includes storage instructions, dosage information, and cautions. The label design features an orange band with the brand name and dosage strength prominently displayed.*

FDA Label Image

1.25 250ml Ctn (Tyzavan Vancomycin Injection 16)

TYZAVAN 1.25 g/250 mL (5 mg/mL) vancomycin injection, USP packaging label for intravenous infusion. The label indicates a 1.25-gram strength in a 250 mL flexible bag, labeled as ready to use. Manufactured for Hikma Pharmaceuticals USA Inc., the label includes storage instructions to keep between 15°C to 25°C (59°F to 77°F) and notes it is for prescription use only, sterile, and single-dose (six flexible bags per package).*

FDA Label Image

1.5g 300ml Bag (Tyzavan Vancomycin Injection 17)

TYZAVAN 1.5 g/300 mL (5 mg/mL) vancomycin injection, USP in a single-dose flexible intravenous infusion bag. Label indicates sterile, nonpyrogenic solution, ready to use, for intravenous infusion only. Manufactured for Hikma Pharmaceuticals USA Inc., made in Switzerland. Includes storage instructions and cautionary notes. Label highlights new formulation and features a barcode.*

FDA Label Image

1.5g 300ml Ow (Tyzavan Vancomycin Injection 18)

Label for TYZAVAN (vancomycin injection, USP) intravenous solution, 1.5 g/300 mL (5 mg/mL) strength. The label states the product is a single-dose flexible bag, sterile and nonpyrogenic, ready to use. It includes dosage guidance references and cautions, and identifies Hikma Pharmaceuticals USA Inc. as the manufacturer. The label features a barcode and storage instructions.*

FDA Label Image

1.5g 300ml Ctn (Tyzavan Vancomycin Injection 19)

Carton label for TYZAVAN 1.5 g/300 mL (5 mg/mL) vancomycin injection USP, a sterile intravenous solution. The packaging states it is ready to use and is labeled for intravenous infusion only. The labeler is Hikma Pharmaceuticals USA Inc. Storage instructions specify 15°C to 25°C (59°F to 77°F).*

FDA Label Image

Hikma Logo (Tyzavan Vancomycin Injection 2)

FDA Label Image

1.75 350ml Bag (Tyzavan Vancomycin Injection 20)

TYZAVAN vancomycin injection USP 1.75 g/350 mL (5 mg/mL) single-dose flexible bag for intravenous infusion. The sterile, nonpyrogenic solution is labeled as a new formulation and ready to use. Label includes storage instructions and manufacturing information for Hikma Pharmaceuticals USA Inc., made in Switzerland.*

FDA Label Image

1.75g 350ml Ow (Tyzavan Vancomycin Injection 21)

TYZAVAN 1.75 g/350 mL (vancomycin injection, USP) intravenous injection solution in a single-dose flexible bag. The label states it is sterile, nonpyrogenic, ready to use with a new formulation, and manufactured by Hikma Pharmaceuticals USA, Inc. The label includes storage instructions, cautions, and detailed concentration per 100 mL, along with barcode and lot/expiration placeholders.*

FDA Label Image

1.75 350ml Ctn (Tyzavan Vancomycin Injection 22)

TYZAVAN 1.75 g/350 mL (5 mg/mL) vancomycin injection, USP, intravenous infusion solution. The packaging label displays a single-dose flexible bag with instructions for storage at 15°C to 25°C (59°F to 77°F) and discarding unused portions. The labeler is Hikma Pharmaceuticals USA Inc., featuring a modern design with hexagonal patterns and the notation 'New Formulation.'*

FDA Label Image

2g 400ml Bag (Tyzavan Vancomycin Injection 23)

Label for TYZAVAN 2 g/400 mL (5 mg/mL) vancomycin injection, USP, intravenous solution in a single-dose flexible bag. The label states it is sterile and nonpyrogenic, highlights a new formulation, and indicates the product is ready to use. It is manufactured by Hikma Pharmaceuticals USA Inc. and made in Switzerland.*

FDA Label Image

2g 400ml Ow (Tyzavan Vancomycin Injection 24)

TYZAVAN 2 g/400 mL (5 mg/mL) vancomycin injection, USP, in a single-dose flexible bag for intravenous infusion. Label highlights a new formulation, ready to use, sterile and nonpyrogenic solution. Manufactured by Hikma Pharmaceuticals USA Inc., with storage and usage cautions included. Made in Switzerland, revision dated March 2025.*

FDA Label Image

2g 400ml Ctn (Tyzavan Vancomycin Injection 25)

Packaging label for TYZAVAN 2 g/400 mL (5 mg/mL) vancomycin injection, USP, an intravenous solution by Hikma Pharmaceuticals USA Inc. The label indicates the product is a ready-to-use, sterile infusion solution in flexible bags, containing six single-dose bags per outer package. Storage instructions specify 15°C to 25°C (59°F to 77°F).*

FDA Label Image

Bag (Tyzavan Vancomycin Injection 3)

Label for TYZAVAN 500 mg/100 mL (vancomycin injection, USP) intravenous infusion single-dose flexible bag. The label indicates sterile, nonpyrogenic solution with a concentration of 5 mg/mL, ready to use. It includes storage instructions, cautions, manufacturer details (Hikma Pharmaceuticals USA, made in Switzerland), and a barcode.*

FDA Label Image

500mg Ow (Tyzavan Vancomycin Injection 4)

Label for TYZAVAN vancomycin injection, USP 500 mg/100 mL (5 mg/mL) solution in a single-dose flexible bag. The label notes it is sterile, nonpyrogenic, ready to use, and for intravenous infusion only. It includes cautions about storage and use, manufacturer Hikma Pharmaceuticals USA Inc., and barcode details.*

FDA Label Image

Ctn (Tyzavan Vancomycin Injection 5)

Packaging label for TYZAVAN 500 mg/100 mL (5 mg/mL) vancomycin injection, USP in an intravenous injection solution form. The label indicates six single-dose flexible bags per package and features yellow and gray hexagonal design elements. Manufactured by Hikma Pharmaceuticals USA Inc., the label also states storage instructions and that the product is ready to use and sterile.*

FDA Label Image

500mg Ctn 12 (Tyzavan Vancomycin Injection 6)

TYZAVAN 500 mg/100 mL (vancomycin injection, USP) intravenous infusion solution packaging label. The label states 'Ready To Use' and includes storage instructions to store at 15°C to 25°C (59°F to 77°F) in the original package. Manufactured by Hikma Pharmaceuticals USA Inc., the package contains twelve single-dose flexible bags.*

FDA Label Image

750mg Bag Label (Tyzavan Vancomycin Injection 7)

Label for TYZAVAN (vancomycin injection, USP) 750 mg/150 mL (5 mg/mL) intravenous injection, solution. The label indicates a single-dose flexible bag, sterile and nonpyrogenic, ready to use with no additives. It includes dosage instructions, storage conditions, active ingredient content per 100 mL, manufacturer Hikma Pharmaceuticals USA Inc., and mentions a new formulation with barcode and expiration, lot, and outlet port details.*

FDA Label Image

750mg Ow (Tyzavan Vancomycin Injection 8)

Label for TYZAVAN (vancomycin injection, USP) 750 mg/150 mL (5 mg/mL) intravenous injection solution in a single-dose flexible bag. The label highlights it is a new formulation, sterile, nonpyrogenic, and ready to use. It includes storage instructions, cautions, manufacturing information by Hikma Pharmaceuticals USA Inc., and barcodes.*

FDA Label Image

750mg-150ml Ctn06 (Tyzavan Vancomycin Injection 9)

Packaging label for TYZAVAN 750 mg/150 mL (vancomycin injection, USP) intravenous solution. The label indicates the product is ready to use and includes storage instructions from 15°C to 25°C (59°F to 77°F). The labeler is Hikma Pharmaceuticals USA Inc. The package contains six single-dose flexible bags.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.